Obstructive sleep apnoea and hypertension: A growing clinical challenge

Hellenic Journal of Cardiology

Volumn 49, Issue 5, 2008, Pages 299-302

  Tsioufis, Costas ^a,b   Thomopoulos, Costas ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Hypertension; Sleep apnoea

Indexed keywords

AIRWAY PRESSURE; BLOOD PRESSURE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPOXIA; PHENOTYPE; REM SLEEP; RISK FACTOR; SLEEP APNEA SYNDROME;

EID: 57349113007     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007; 25: 1751-1762.
2. Calhoun DA, Jones D, Textor S, et al; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008; 117: e510-526.
3. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006; 28: 596-602.
4. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046-1053.
5. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol. 2005; 99: 1998-2007.
6. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008; 5: 136-143.
7. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342: 1378-1384.
8. Staessen J, Bulpitt CJ, O'Brien E, et al. The diurnal blood pressure profile. A population study. Am J Hypertens. 1992; 5: 386-392.
9. Somers VK, Dyken ME, Mark AL, et al. Sympathetic nerve activity during sleep in normal subjects. N Engl J Med. 1993; 328: 303-307.
10. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnea in drug resistant hypertension. J Hypertens. 2001; 19: 2271-2277.
11. Konstantopoulou AS, Papargyriou IK, Antoniadou ES, Konstantopoulou PS, Papadogiannis DE. Masked hypertension: a new entity under investigation. Hellenic J Cardiol. 2006; 47: 232-235.
12. Gangwisch JE, Malaspina D, Boden-Albala B, et al. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005; 28: 1289-1296.
13. Egan BM. Sleep and hypertension: burning the candle at both ends really is hazardous to your health. Hypertension. 2006; 47: 816-817.
14. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short-sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006; 29: 833-839.
15. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: The Sleep Heart Health Study. Sleep. 2006; 29: 1009-1014.
16. Chrysostomakis SI, Simantirakis EN, Schiza SE, et al. Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome. Hellenic J Cardiol. 2006; 47: 13-20.
17. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation. 1999; 99: 1183-1189.
18. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-h ambulatory blood pressure. Hypertension. 2006; 47: 840-845.
19. Thomopoulos C, Tsioufis C, Dimitriadis K, et al. Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives. J Hum Hypertens 2008; doi:10.1038/jhh.2008.101.
20. Tsioufis C, Dimitriadis K, Stefanadis C, Kallikazaros I. The emerging role of subclinical inflammation in hypertension-associated early renal dysfunction: focus on microalbuminuria. Hellenic J Cardiol. 2006; 47: 361-365.
21. Kato M, Roberts-Thompson P, Phillips B. Impairment of endothelium dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000; 102: 2607-2610.
22. Strohl KP, Novak RD, Singer W, et al. Insulin levels, blood pressure and sleep apnea. Sleep. 1994; 17: 614-618.
23. Ambrosini G, Nath AK, Sierra-Honigmann MR, Flores-Riveros J. Transcriptional activation of the human leptin gene in response to hypoxia. J Biol Chem. 2002; 277: 34601-34609.
24. Floras JS, Bradley TD. Treating obstructive sleep apnea: is there more to the story than 2 millimeters of mercury? Hypertension. 2007; 50: 289-291.
25. Tsioufis C, Thomopoulos K, Dimitriadis K, et al. The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens. 2007; 25: 141-144.
26. Tsioufis C, Thomopoulos K, Dimitriadis K, et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis. 2008; 52: 285-293.